FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2058786507> ?p ?o ?g. }

• W2058786507 endingPage "104" @default.
• W2058786507 startingPage "95" @default.
• W2058786507 abstract "Nanocarriers can selectively target cancer sites and carry payloads, thereby improving diagnostic and therapeutic effectiveness and reducing toxicity. The objective of this study was to investigate the therapeutic efficacy of a new co-delivery radiochemotherapeutics of 188Re-N,N-bis (2-mercaptoethyl)-N′,N′-diethylethylenediamine (BMEDA)-labeled pegylated liposomal doxorubicin (DXR) (188Re-DXR-liposome) in a C26 murine colon carcinoma solid tumor model. To evaluate the targeting and localization of 188Re-DXR-liposome in C26 murine tumor-bearing mice, biodistribution, microSPECT/CT imaging and pharmacokinetic studies were performed. The antitumor effect of 188Re-DXR-liposome was assessed by tumor growth inhibition, survival ratio and histopathological hematoxylin–eosin staining. The tumor target and localization of the nanoliposome delivery radiochemotherapeutics of 188Re-DXR-liposome were demonstrated in the biodistribution, pharmacokinetics and in vivo nuclear imaging studies. In the study on therapeutic efficacy, the tumor-bearing mice treated with bimodality radiochemotherapeutics of 188Re-DXR-liposome showed better mean tumor growth inhibition rate (MGI) and longer median survival time (MGI=0.048; 74 days) than those treated with radiotherapeutics of 188Re-liposome (MGI=0.134; 60 days) and chemotherapeutics of Lipo-Dox (MGI=0.413; 38 days). The synergistic tumor regression effect was observed with the combination index (CI) exceeding 1 (CI=1.145) for co-delivery radiochemotherapeutics of 188Re-DXR-liposome. Two (25%) of the mice treated with radiochemotherapeutics were completely cured after 120 days. The therapeutic efficacy of radiotherapeutics of 188Re-liposome and the synergistic effect of the combination radiochemotherapeutics of 188Re-DXR-liposome have been demonstrated in a C26 murine solid tumor animal model, which pointed to the potential benefit and promise of the co-delivery of nanoliposome radiochemotherapeutics for adjuvant cancer treatment on oncology applications." @default.
• W2058786507 created "2016-06-24" @default.
• W2058786507 creator A5003261770 @default.
• W2058786507 creator A5008570342 @default.
• W2058786507 creator A5015891266 @default.
• W2058786507 creator A5029313920 @default.
• W2058786507 creator A5036399590 @default.
• W2058786507 creator A5038656475 @default.
• W2058786507 creator A5057241756 @default.
• W2058786507 creator A5087109427 @default.
• W2058786507 date "2010-01-01" @default.
• W2058786507 modified "2023-10-16" @default.
• W2058786507 title "Therapeutic efficacy and microSPECT/CT imaging of 188Re-DXR-liposome in a C26 murine colon carcinoma solid tumor model" @default.
• W2058786507 cites W1989195046 @default.
• W2058786507 cites W2001601360 @default.
• W2058786507 cites W2013470095 @default.
• W2058786507 cites W2028294113 @default.
• W2058786507 cites W2038680276 @default.
• W2058786507 cites W2046582475 @default.
• W2058786507 cites W2048834254 @default.
• W2058786507 cites W2060113976 @default.
• W2058786507 cites W2061510929 @default.
• W2058786507 cites W2067403798 @default.
• W2058786507 cites W2082511916 @default.
• W2058786507 cites W2095248480 @default.
• W2058786507 cites W2099259685 @default.
• W2058786507 cites W2100189272 @default.
• W2058786507 cites W2102449174 @default.
• W2058786507 cites W2121539532 @default.
• W2058786507 cites W2135931701 @default.
• W2058786507 cites W2146595692 @default.
• W2058786507 cites W2159636814 @default.
• W2058786507 cites W236637588 @default.
• W2058786507 doi "https://doi.org/10.1016/j.nucmedbio.2009.08.006" @default.
• W2058786507 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20122674" @default.
• W2058786507 hasPublicationYear "2010" @default.
• W2058786507 type Work @default.
• W2058786507 sameAs 2058786507 @default.
• W2058786507 citedByCount "70" @default.
• W2058786507 countsByYear W20587865072012 @default.
• W2058786507 countsByYear W20587865072013 @default.
• W2058786507 countsByYear W20587865072014 @default.
• W2058786507 countsByYear W20587865072015 @default.
• W2058786507 countsByYear W20587865072016 @default.
• W2058786507 countsByYear W20587865072017 @default.
• W2058786507 countsByYear W20587865072018 @default.
• W2058786507 countsByYear W20587865072019 @default.
• W2058786507 countsByYear W20587865072020 @default.
• W2058786507 countsByYear W20587865072021 @default.
• W2058786507 countsByYear W20587865072022 @default.
• W2058786507 countsByYear W20587865072023 @default.
• W2058786507 crossrefType "journal-article" @default.
• W2058786507 hasAuthorship W2058786507A5003261770 @default.
• W2058786507 hasAuthorship W2058786507A5008570342 @default.
• W2058786507 hasAuthorship W2058786507A5015891266 @default.
• W2058786507 hasAuthorship W2058786507A5029313920 @default.
• W2058786507 hasAuthorship W2058786507A5036399590 @default.
• W2058786507 hasAuthorship W2058786507A5038656475 @default.
• W2058786507 hasAuthorship W2058786507A5057241756 @default.
• W2058786507 hasAuthorship W2058786507A5087109427 @default.
• W2058786507 hasConcept C112705442 @default.
• W2058786507 hasConcept C126322002 @default.
• W2058786507 hasConcept C150903083 @default.
• W2058786507 hasConcept C178790620 @default.
• W2058786507 hasConcept C185154212 @default.
• W2058786507 hasConcept C185592680 @default.
• W2058786507 hasConcept C202751555 @default.
• W2058786507 hasConcept C207001950 @default.
• W2058786507 hasConcept C2776694085 @default.
• W2058786507 hasConcept C2777807558 @default.
• W2058786507 hasConcept C2779820397 @default.
• W2058786507 hasConcept C2781303535 @default.
• W2058786507 hasConcept C502942594 @default.
• W2058786507 hasConcept C55493867 @default.
• W2058786507 hasConcept C71924100 @default.
• W2058786507 hasConcept C86803240 @default.
• W2058786507 hasConcept C98274493 @default.
• W2058786507 hasConceptScore W2058786507C112705442 @default.
• W2058786507 hasConceptScore W2058786507C126322002 @default.
• W2058786507 hasConceptScore W2058786507C150903083 @default.
• W2058786507 hasConceptScore W2058786507C178790620 @default.
• W2058786507 hasConceptScore W2058786507C185154212 @default.
• W2058786507 hasConceptScore W2058786507C185592680 @default.
• W2058786507 hasConceptScore W2058786507C202751555 @default.
• W2058786507 hasConceptScore W2058786507C207001950 @default.
• W2058786507 hasConceptScore W2058786507C2776694085 @default.
• W2058786507 hasConceptScore W2058786507C2777807558 @default.
• W2058786507 hasConceptScore W2058786507C2779820397 @default.
• W2058786507 hasConceptScore W2058786507C2781303535 @default.
• W2058786507 hasConceptScore W2058786507C502942594 @default.
• W2058786507 hasConceptScore W2058786507C55493867 @default.
• W2058786507 hasConceptScore W2058786507C71924100 @default.
• W2058786507 hasConceptScore W2058786507C86803240 @default.
• W2058786507 hasConceptScore W2058786507C98274493 @default.
• W2058786507 hasIssue "1" @default.
• W2058786507 hasLocation W20587865071 @default.
• W2058786507 hasLocation W20587865072 @default.
• W2058786507 hasOpenAccess W2058786507 @default.

• next